Manager × security

Knott David M Jr TVTX holdings history

Who else holds this security? →

TRAVERE THERAPEUTICS INC · CUSIP 89422G107 · CIK 1892770

Some filings reported values in thousands; those figures were scaled ×1000 to dollars.
This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Knott David M Jr reported 147.28K TVTX (shares), valued at $8.37M, or 4.42% of its reported non-derivative portfolio. Filed 2026-08-12.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
4.42%
Shares
147.28K
147,282
Reported value
$8.37M
USD

Shares increased 4.73%; reported value increased 100.26%, and weight changed +1.93 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20264.42%147,282SEC filing ↗Filed Aug 12, 2026
Q1 20262.49%140,633SEC filing ↗Filed May 14, 2026
Q4 20253.29%186,000SEC filing ↗Filed Feb 12, 2026
Q3 20252.60%260,000SEC filing ↗Filed Nov 12, 2025
Q2 20251.74%260,000SEC filing ↗Filed Aug 11, 2025
Q1 20251.93%228,000SEC filing ↗Filed May 12, 2025
Q4 20241.44%228,000SEC filing ↗Filed Feb 12, 2025
Q3 20241.27%258,231SEC filing ↗Filed Nov 13, 2024
Q2 20240.87%265,966SEC filing ↗Filed Aug 12, 2024
Q1 20240.63%230,966SEC filing ↗Filed May 14, 2024
Q4 20230.76%221,005SEC filing ↗Filed Feb 13, 2024
Q3 20230.34%100,317SEC filing ↗Filed Nov 13, 2023

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20230.34%100,317$897.00KThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Nov 13, 2023
Q4 20230.76%221,005$1.99MShares increased 120.31%; reported value increased 121.52%, and weight changed +0.42 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 13, 2024
Q1 20240.63%230,966$1.78MShares increased 4.51%; reported value decreased 10.37%, and weight changed -0.13 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2024
Q2 20240.87%265,966$2.19MShares increased 15.15%; reported value increased 22.74%, and weight changed +0.24 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 12, 2024
Q3 20241.27%258,231$3.61MShares decreased 2.91%; reported value increased 65.28%, and weight changed +0.40 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 13, 2024
Q4 20241.44%228,000$3.97MShares decreased 11.71%; reported value increased 9.93%, and weight changed +0.17 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 12, 2025
Q1 20251.93%228,000$4.09MShares unchanged; reported value increased 2.87%, and weight changed +0.49 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 12, 2025
Q2 20251.74%260,000$3.85MShares increased 14.04%; reported value decreased 5.82%, and weight changed -0.19 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 11, 2025
Q3 20252.60%260,000$6.21MShares unchanged; reported value increased 61.49%, and weight changed +0.86 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 12, 2025
Q4 20253.29%186,000$7.11MShares decreased 28.46%; reported value increased 14.37%, and weight changed +0.69 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 12, 2026
Q1 20262.49%140,633$4.18MShares decreased 24.39%; reported value decreased 41.21%, and weight changed -0.80 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2026
Q2 20264.42%147,282$8.37MShares increased 4.73%; reported value increased 100.26%, and weight changed +1.93 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 12, 2026
Knott David M Jr · TRAVERE THERAPEUTICS INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1892770","quarter":"2026Q2","cusip":"89422G107"}

get_institutional_manager_history
{"cik":"1892770","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.